|
YPEL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.026400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.821000E-01 |
| Normal-vs-Stage2 |
1.321580E-01 |
| Normal-vs-Stage3 |
2.930200E-01 |
| Normal-vs-Stage4 |
3.365200E-01 |
| Stage1-vs-Stage2 |
1.747870E-02 |
| Stage1-vs-Stage3 |
1.356050E-02 |
| Stage1-vs-Stage4 |
7.052300E-02 |
| Stage2-vs-Stage3 |
4.570200E-01 |
| Stage2-vs-Stage4 |
5.687200E-01 |
| Stage3-vs-Stage4 |
9.261200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.548000E-01 |
| Normal-vs-AfricanAmerican |
7.980600E-01 |
| Normal-vs-Asian |
1.410830E-01 |
| Caucasian-vs-AfricanAmerican |
5.969000E-01 |
| Caucasian-vs-Asian |
1.705560E-01 |
| AfricanAmerican-vs-Asian |
2.298200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.507000E-01 |
| Normal-vs-Female |
7.004200E-01 |
| Male-vs-Female |
7.424100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.421900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.818800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.137800E-03 |
| Normal-vs-Age(81-100Yrs) |
4.275000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.335600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.13269999958111E-07 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.867200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.157400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.688800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.292400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.497820E-01 |
| Classical-VS-Follicular |
2.80159995202922E-09 |
| Classical-VS-Other |
5.858800E-01 |
| Classical-VS-Normal |
7.494200E-02 |
| Tall-VS-Follicular |
2.589800E-02 |
| Tall-VS-Other |
3.733200E-01 |
| Tall-VS-Normal |
6.743200E-01 |
| Follicular-VS-Other |
1.462190E-01 |
| Follicular-VS-Normal |
3.198800E-04 |
| Other-VS-Normal |
4.184000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.681200E-01 |
| Normal-vs-N1 |
7.841600E-01 |
| N0-vs-N1 |
3.522800E-01 |
|
|
